C
Coya Therapeutics D
D
COYA
6.74000
USD
0.30
(4.64%)
Market Closed
Volume
771
EPS
-1
Div Yield
-
P/E
-10
Market Cap
112,608,152
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Coya Therapeutics
Sector: Healthcare
Industry: Biotechnology
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.